UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genetic and enzymatic characterization of Amy13E from Cellvibrio japonicus reclassifies it as a cyclodextrinase also capable of α-diglucoside degradation

Applied and environmental microbiology, 2024-01, Vol.90 (1), p.e0152123

2024

Volltextzugriff (PDF)

Comparison of exhaled nitric oxide measurements between NIOX MINO® electrochemical and Ecomedics chemiluminescence analyzer

Respiratory medicine, 2008-11, Vol.102 (11), p.1667-1671

2008

Volltextzugriff (PDF)

Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease

Clinical and experimental allergy, 2009-08, Vol.39 (8), p.1179-1186

2009

Volltextzugriff (PDF)

Analysis of GPIIb/IIIa Receptor Number by Quantification of 7E3 Binding to Human Platelets

Blood, 1996-08, Vol.88 (3), p.907-914

1996

Volltextzugriff (PDF)

Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade

Circulation (New York, N.Y.), 1998-05, Vol.97 (17), p.1680-1688

1998

Volltextzugriff (PDF)

Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis

Allergy, 2007-04, Vol.62 (4), p.378-384

2007

Volltextzugriff (PDF)

Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization

Circulation (New York, N.Y.), 2001-07, Vol.104 (2), p.163-167

2001

Volltextzugriff (PDF)

Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists

Circulation (New York, N.Y.), 2000-03, Vol.101 (9), p.1013-1018

2000

Volltextzugriff (PDF)

Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy

Journal of the American College of Cardiology, 2000-07, Vol.36 (1), p.75-83

2000

Volltextzugriff (PDF)

Comparison of biomarkers between allergic rhinitis only and allergic rhinitis with concomitant asthma

Allergy (Copenhagen), 2009-07, Vol.64 (7), p.1102-1103

2009

Volltextzugriff (PDF)

GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole blood

Thrombosis and haemostasis, 2000-09, Vol.84 (3), p.492-498

2000

Volltextzugriff (PDF)

Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation

The Journal of experimental medicine, 1990, Vol.171 (1), p.265-297

1990

Volltextzugriff (PDF)

Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy

Circulation (New York, N.Y.), 1997-12, Vol.96 (11), p.3860-3866

1997

Volltextzugriff (PDF)

High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: Results from TIMI (Thrombolysis In Myocardial Infarction) 14

Circulation (New York, N.Y.), 2000-06, Vol.101 (23), p.2690-2695

2000

Volltextzugriff (PDF)

Ig H and L chain contributions to autoimmune specificities

The Journal of immunology (1950), 1991-01, Vol.146 (1), p.176-182

1991

Volltextzugriff (PDF)

Abciximab readministration: Results of the reopro readministration registry

Circulation (New York, N.Y.), 2001-08, Vol.104 (8), p.870-875

2001

Volltextzugriff (PDF)

Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade

Developments in biologicals, 2003, Vol.112, p.37

2003

Volltextzugriff (PDF)

Molecular profiling and gene expression analysis in cutaneous sarcoidosis: The role of interleukin-12, interleukin-23, and the T-helper 17 pathway

Journal of the American Academy of Dermatology, 2012-06, Vol.66 (6), p.901-910.e2

2012

Volltextzugriff (PDF)

In Vitro Dose Response to Different GPIIb/IIIa-Antagonists: Inter-Laboratory Comparison of Various Platelet Function Tests

Thrombosis research, 2001-04, Vol.102 (1), p.39-48

2001

Volltextzugriff (PDF)

Effects of abciximab, ticlopidine, and combined abciximab/ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty

Circulation (New York, N.Y.), 2000-03, Vol.101 (10), p.1122-1129

2000

Volltextzugriff (PDF)

Applicability and reproducibility of biomarkers for the evaluation of anti-inflammatory therapy in allergic rhinitis

Journal of investigational allergology & clinical immunology, 2008, Vol.18 (6), p.433-442

2008

Volltextzugriff (PDF)

Therapeutic heparin concentrations augment platelet reactivity: Implications for the pharmacologic assessment of the glycoprotein IIb/IIIa antagonist abciximab

The American heart journal, 2000-04, Vol.139 (4), p.696-703

2000

Volltextzugriff (PDF)

Anti-platelet factor 4/heparin antibodies: An independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes

Circulation (New York, N.Y.), 2003-05, Vol.107 (18), p.2307-2312

2003

Volltextzugriff (PDF)

Mechanisms of Monoclonal Antibody-Drug Interactions

Annual review of pharmacology and toxicology, 2011-01, Vol.51 (1), p.359-372

2011

Volltextzugriff (PDF)

119 RELATIONSHIPS AMONG AND DISCRIMINATORY ABILITY OF INFLAMMATORY MEDIATORS IN SERUM AND SYNOVIAL FLUID IN A CROSS-SECTIONAL OSTEOARTHRITIS COHORT

Osteoarthritis and cartilage, 2007, Vol.15, p.C75-C75

2007

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(89)
Tagungsberichte
(2)

Sprache

Englisch
(90)
Italienisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Genetic and enzymatic characterization of Amy13E from Cellvibrio japonicus reclassifies it as a cyclodextrinase also capable of α-diglucoside degradation

Comparison of exhaled nitric oxide measurements between NIOX MINO® electrochemical and Ecomedics chemiluminescence analyzer

Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease

Analysis of GPIIb/IIIa Receptor Number by Quantification of 7E3 Binding to Human Platelets

Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade

Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis

Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization

Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists

Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy

Comparison of biomarkers between allergic rhinitis only and allergic rhinitis with concomitant asthma

GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole blood

Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation

Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy

High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: Results from TIMI (Thrombolysis In Myocardial Infarction) 14

Ig H and L chain contributions to autoimmune specificities

Abciximab readministration: Results of the reopro readministration registry

Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade

Molecular profiling and gene expression analysis in cutaneous sarcoidosis: The role of interleukin-12, interleukin-23, and the T-helper 17 pathway

In Vitro Dose Response to Different GPIIb/IIIa-Antagonists: Inter-Laboratory Comparison of Various Platelet Function Tests

Effects of abciximab, ticlopidine, and combined abciximab/ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty

Applicability and reproducibility of biomarkers for the evaluation of anti-inflammatory therapy in allergic rhinitis

Therapeutic heparin concentrations augment platelet reactivity: Implications for the pharmacologic assessment of the glycoprotein IIb/IIIa antagonist abciximab

Anti-platelet factor 4/heparin antibodies: An independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes

Mechanisms of Monoclonal Antibody-Drug Interactions

119 RELATIONSHIPS AMONG AND DISCRIMINATORY ABILITY OF INFLAMMATORY MEDIATORS IN SERUM AND SYNOVIAL FLUID IN A CROSS-SECTIONAL OSTEOARTHRITIS COHORT

Suchergebnisse filtern